ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, 25
N. diseases: 395; N. variants: 37
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 9 | 130872153 | missense variant | T/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 5 | 2004 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130872201 | missense variant | G/C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.730 | 1.000 | 4 | 2009 | 2019 | ||||||||
|
1.000 | 0.080 | 9 | 130872895 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.160 | 9 | 130872901 | missense variant | T/A;C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 2 | 2008 | 2011 | ||||||||
|
1.000 | 0.080 | 9 | 130872902 | missense variant | T/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.080 | 9 | 130873028 | missense variant | T/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.080 | 9 | 130878519 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.827 | 0.120 | 9 | 130862976 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.730 | 1.000 | 18 | 2001 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862977 | missense variant | A/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 10 | 2001 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130873016 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 8 | 2002 | 2014 | ||||||||
|
0.851 | 0.160 | 9 | 130872903 | missense variant | C/A;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 12 | 2002 | 2014 | ||||||||
|
0.851 | 0.080 | 9 | 130873027 | missense variant | T/A;C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.740 | 1.000 | 14 | 2003 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862962 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 8 | 2002 | 2014 | ||||||||
|
0.925 | 0.080 | 9 | 130874969 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 8 | 2002 | 2016 | ||||||||
|
1.000 | 0.080 | 9 | 130862955 | missense variant | C/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 6 | 2003 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862943 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 10 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130873004 | missense variant | T/C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 15 | 2002 | 2014 | ||||||||
|
1.000 | 0.080 | 9 | 130862969 | missense variant | G/C;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 6 | 2002 | 2014 | ||||||||
|
0.672 | 0.160 | 9 | 130872896 | missense variant | C/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.800 | 0.943 | 105 | 2001 | 2020 | ||||||||
|
0.925 | 0.080 | 9 | 130862971 | missense variant | A/T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.720 | 1.000 | 6 | 2002 | 2014 | ||||||||
|
0.851 | 0.120 | 9 | 130862970 | missense variant | T/C | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 16 | 2002 | 2014 | ||||||||
|
0.925 | 0.160 | 9 | 130854977 | missense variant | G/A | snv | 7.0E-06 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 9 | 130862953 | missense variant | A/G | snv | 2.6E-03 | 2.5E-03 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | < 0.001 | 1 | 2005 | 2005 | ||||||
|
0.827 | 0.120 | 9 | 130862919 | missense variant | G/A | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.730 | 1.000 | 4 | 2006 | 2013 |